文献速递临床生化质量管理与危急值

糖化白蛋白标准化在糖尿病患者评估中的局限性

Limitations of glycated albumin standardization when applied to the assessment of diabetes patients.
PubMed 文献 · Clin Chem Lab Med · 2024-06-17

该研究验证了Norudia糖化白蛋白(GA)和Lucica GA-L两种方法的精密度与正确度,并在1,167例患者样本中比较两种方法以mmol/mol和%报告的结果差异。结果显示两种方法在mmol/mol下的患者样本结果差异显著,而JCCRM611-1参考物质未能反映此差异,提示GA标准化存在局限性。

要点

  • Lucica和Norudia方法在mmol/mol下患者样本结果差异显著,%单位下差异较小。
  • JCCRM611-1参考物质未能揭示两种方法在患者样本中的差异。
  • GA标准化可借鉴HbA1c标准化的经验与教训。

核心结论

  • 两种方法在患者样本中以mmol/mol报告的结果差异显著,而以%报告时差异较小。
  • 患者样本与JCCRM611-1参考物质表现不同,原因尚不明确。

研究设计与样本

  • 采用CLSI-EP15-A3方案使用厂家质控品验证不精密度。
  • 对JCCRM611-1参考物质测量20次以评估两种方法的正确度。
  • 在1,167例患者样本中测量GA,比较两种方法以mmol/mol和%报告的结果。

主要发现

  • Lucica方法质控品最大CV≤0.6%,Norudia方法质控品最大CV≤1.8%。
  • 两种方法测量JCCRM611-1的mmol/mol和%结果均在赋值不确定度范围内。
  • 患者样本中两种方法mmol/mol相对差异从GA 183 mmol/mol时的-10.4%到GA 538 mmol/mol时的+8.7%。
  • 患者样本中两种方法%单位相对差异从GA 9.9%时的0%到GA 30%时的+1.7%。

局限性

  • 患者样本与JCCRM611-1参考物质表现不同的原因尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Glycated albumin (GA) has potential value in the management of people with diabetes; however, to draw meaningful conclusions between clinical studies it is important that the GA values are comparable. This study investigates the standardization of the Norudia Glycated Albumin and Lucica Glycated Albumin-L methods. METHODS: The manufacturer reported imprecision was verified by performing CLSI-EP15-A3 protocol using manufacturer produced controls. The Japanese Clinical Chemistry Reference Material (JCCRM)611-1 was measured 20 times to evaluate the accuracy of both methods. GA was also measured in 1,167 patient samples and results were compared between the methods in mmol/mol and %. RESULTS: Maximum CV for Lucica was ≤0.6 % and for Norudia ≤1.8 % for control material. Results in mmol/mol and % of the JCCRM611-1 were within the uncertainty of the assigned values for both methods. In patient samples the relative difference in mmol/mol between the two methods ranged from -10.4 % at a GA value of 183 mmol/mol to +8.7 % at a GA value of 538 mmol/mol. However, the relative difference expressed in percentage units ranged from of 0 % at a GA value of 9.9 % to +1.7 % at a GA value of 30 %. CONCLUSIONS: The results in mmol/mol between the two methods for the patient samples were significantly different compared to the results in %. It is not clear why patient samples behave differently compared to JCCRM611-1 material. Valuable lessons can be learnt from comparing the standardization process of GA with that of HbA1c.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Lenters-Westra E, Atkin SL, Kilpatrick ES, et al. Limitations of glycated albumin standardization when applied to the assessment of diabetes patients. Clin Chem Lab Med. 2024. PMID: 38874995. doi:10.1515/cclm-2024-0591

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。